INBX short interest
Inhibrx Biosciences Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 3,432,642 |
|---|---|
| Change vs prior report | 39,131 (+1.1%) |
| Change over six months | +62.0% |
| Days to cover | 11.82 (sector: 3.78) |
| Average daily volume | 290,359 |
| Rank in Healthcare | #72 of 922 by days to cover |
INBX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 3,432,642 | +1.1% | 11.82 | 290,359 |
| 2026-09-15 | 3,393,511 | +2.9% | 8.31 | 408,480 |
| 2026-08-31 | 3,297,743 | +2.6% | 10.39 | 317,496 |
| 2026-08-14 | 3,215,230 | -3.8% | 14.39 | 223,490 |
| 2026-07-31 | 3,341,210 | -2.7% | 15.64 | 213,594 |
| 2026-07-15 | 3,433,872 | -0.4% | 9.04 | 379,873 |
| 2026-06-30 | 3,447,032 | +4.5% | 9.91 | 347,713 |
| 2026-06-15 | 3,299,693 | +3.8% | 10.25 | 321,930 |
| 2026-05-29 | 3,179,335 | +8.4% | 9.32 | 341,252 |
| 2026-05-15 | 2,932,658 | +7.3% | 4.48 | 654,241 |
| 2026-04-30 | 2,733,548 | +27.9% | 3.97 | 687,984 |
| 2026-04-15 | 2,136,978 | +0.8% | 8.66 | 246,794 |
| 2026-03-31 | 2,119,421 | +13.7% | 8.58 | 247,014 |
| 2026-03-13 | 1,864,224 | +7.9% | 10.40 | 179,297 |
| 2026-02-27 | 1,727,284 | -0.4% | 11.23 | 153,759 |
| 2026-02-13 | 1,734,575 | -0.2% | 11.11 | 156,185 |
| 2026-01-30 | 1,737,927 | +5.3% | 7.15 | 243,093 |
| 2026-01-15 | 1,650,847 | -3.6% | 9.85 | 167,640 |
| 2025-12-31 | 1,712,725 | +63.1% | 6.17 | 277,794 |
| 2025-12-15 | 1,049,942 | -20.5% | 5.33 | 196,978 |
| 2025-11-28 | 1,321,190 | +16.3% | 5.08 | 259,844 |
| 2025-11-14 | 1,136,139 | +10.7% | 3.28 | 346,540 |
| 2025-10-31 | 1,026,055 | +92.6% | 1.00 | 1,026,597 |
| 2025-10-15 | 532,661 | +1.6% | 3.30 | 161,268 |
| 2025-09-30 | 524,531 | -27.3% | 3.52 | 149,004 |
import finzdata as yf
yf.Ticker("INBX").short_interest # every report since 2017
yf.Client().short_interest(["INBX"], start="2018-01-01")Healthcare short interest · INBX price history · Who owns INBX · All short interest